STOCK TITAN

Livechain Stock Price, News & Analysis

LICH OTC Link

Company Description

LiveChain, Inc. (LICH) is a subsidiary of Vyome Holdings, Inc. that is associated with efforts to build a scalable, standalone business within Vyome’s broader corporate structure. According to available information, LiveChain’s shares trade on the OTC Markets under the symbol LICH.

Vyome’s Board of Directors has identified LiveChain as a vehicle through which it seeks to create value for both LiveChain and Vyome shareholders. In this context, LiveChain is being positioned with the objective of becoming financially self-sufficient and developing an independent business that could generate value for its equity holders, subject to execution of its plans and successful completion of contemplated transactions.

Relationship with Vyome Holdings

LiveChain operates as a subsidiary of Vyome Holdings, Inc., which is listed on Nasdaq under the symbol HIND. Vyome’s Board has been engaged in a review of strategic alternatives for LiveChain, and the steps described in recent disclosures are presented as a critical first phase in LiveChain’s evolution toward a more independent operating profile.

A key development for LiveChain is a binding letter of intent (LOI) executed with Remus Capital. Under the terms described in that LOI, LiveChain intends to issue shares of its common stock as consideration for acquiring a senior secured convertible note between Remus and Sociometric Solutions, Inc. doing business as Humanyze. The note is secured by a lien on all of Humanyze’s intellectual property and trade secrets.

The LOI contemplates that this transaction would put LiveChain in control of the Humanyze brand, intellectual property, and other know-how. Humanyze is described as an AI-enabled human resources data and analytics company that focuses on employee interactions within the workplace and uses science-backed analytics and AI-enabled insights to help large, complex companies make workplace improvements.

Strategic Rationale

Vyome’s Board has stated that one of its immediate objectives was to find a way to create value from LiveChain. After evaluating multiple options, the path outlined in the LOI is described as the first step in a plan that could allow LiveChain to become financially self-sufficient and to build an independent business. The contemplated relationship with Humanyze is presented as central to this strategy, with the potential for LiveChain to benefit from Humanyze’s AI-enabled platform and workplace analytics capabilities if the transaction is completed as envisioned.

Statements from Vyome’s leadership emphasize that Humanyze is focused on issues related to human capital in large enterprises, including the cost of developing, retaining, and rewarding employees. They also highlight the view that Humanyze’s platform provides data and insights that can help employers optimize human capital in an environment where humans and AI interact in the workplace.

Transaction Uncertainty

The LOI sets out an expectation that the parties would enter into definitive agreements based on its terms within a specified period and seek to close the transaction after satisfaction of certain conditions precedent. However, it is explicitly noted that there can be no assurance that the transaction contemplated by the LOI will be consummated. As a result, any description of LiveChain’s future business profile must be understood as contingent on whether definitive agreements are executed and the closing occurs.

Business Focus and Outlook

Based on current disclosures, LiveChain’s near-term focus is tied to the potential acquisition of the senior secured convertible note related to Humanyze and the broader plan to establish a scalable, independent business. The company’s strategic direction is framed around using this transaction as a foundation for financial self-sufficiency and shareholder value creation, subject to the inherent uncertainties of executing the LOI and any subsequent agreements.

Investment Considerations

For investors and observers, LiveChain represents a subsidiary-level entity whose trajectory is closely linked to Vyome’s strategic decisions and to the outcome of the Humanyze-related LOI. The available information emphasizes the potential role of AI-enabled workplace analytics and human capital optimization as thematic elements in LiveChain’s prospective business, while also underscoring that the contemplated transaction may not close.

Stock Performance

$—
0.00%
0.00
Last updated:
+53.85%
Performance 1 year

SEC Filings

No SEC filings available for Livechain.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Livechain (LICH)?

The current stock price of Livechain (LICH) is $0.012 as of February 24, 2026.

What is LiveChain, Inc. (LICH)?

LiveChain, Inc. is a subsidiary of Vyome Holdings, Inc. that trades on the OTC Markets under the symbol LICH. Vyome’s Board has described LiveChain as an entity through which it aims to build a scalable, standalone business and create value for LiveChain and Vyome shareholders.

How is LiveChain related to Vyome Holdings, Inc.?

LiveChain is a subsidiary of Vyome Holdings, Inc., which is listed on Nasdaq under the symbol HIND. Vyome’s Board has conducted a review of strategic alternatives for LiveChain and has identified steps, including a Humanyze-related letter of intent, as part of a plan to develop LiveChain into a more independent, financially self-sufficient business.

What is the Humanyze transaction mentioned in connection with LiveChain?

LiveChain has executed a binding letter of intent with Remus Capital under which it would issue shares of its common stock to acquire a senior secured convertible note between Remus and Sociometric Solutions, Inc. DBA Humanyze. The note is secured by a lien on all of Humanyze’s intellectual property and trade secrets, and the transaction is intended to put LiveChain in control of the Humanyze brand, IP, and related know-how if it is completed.

Who is Humanyze and why is it relevant to LiveChain?

Humanyze is described as an AI-enabled human resources data and analytics company that originated from the MIT Media Lab. It maintains a large database of employee interactions within the workplace and focuses on science-backed analytics and AI-enabled insights to help large, complex companies make workplace improvements. LiveChain’s contemplated acquisition of the senior secured note related to Humanyze is a central element of its strategic plan as outlined by Vyome.

What is the strategic objective for LiveChain according to Vyome’s Board?

Vyome’s Board has stated that an immediate objective was to find a way to create value from LiveChain. The path involving the Humanyze-related LOI is described as the first step in a plan that could enable LiveChain to become financially self-sufficient and build a scalable independent business that may generate value for shareholders, subject to successful completion of the contemplated transaction.

Is the Humanyze-related transaction for LiveChain guaranteed to close?

No. The letter of intent explicitly notes that there can be no assurance that the transaction it contemplates will be consummated. The parties expect to negotiate definitive agreements and pursue closing after certain conditions are satisfied, but completion is not guaranteed.

How does the Humanyze platform relate to human capital management?

Humanyze is described as focusing on one of the major issues facing large companies: human capital and the cost of developing, retaining, and rewarding people. Its AI-enabled platform analyzes data on employee interactions and workplace dynamics to provide insights that can help employers optimize their human capital in a cost-effective way.

What role does Remus Capital play in LiveChain’s plans?

Remus Capital is identified as the counterparty to LiveChain in the binding letter of intent. LiveChain intends to acquire from Remus a senior secured convertible note between Remus and Humanyze, with the note secured by Humanyze’s intellectual property and trade secrets. This acquisition is the mechanism through which LiveChain would gain control over the Humanyze brand and related assets if the transaction is completed.